Wilmington, Delaware, United States, Transparency Market Research Inc., July 05, 2024 (GLOBE NEWSWIRE) -- The global ureteral stents market (marché des stents urétéraux) was projected to attain US$ ...

The results of the study are highly relevant for urological practice. This technology reduces complications and pain for our patients and is a real step forward for patient centered care.” — Professor ...

BARCELONA—A thermo-expandable segmental metallic stent has scored higher than a conventional polyurethane plastic stent on a validated quality of life questionnaire completed by patients with ureteral ...

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. The optimal duration of antibiotic prophylaxis is still unknown.

After years of hearing from patients how bothersome — and sometimes painful — ureteral stents are, Dr. Lee Ponsky, chair of the Department of Urology at University Hospitals, experienced the ...

The RELIEF ureteral stent has achieved FDA clearance as the first and only stent to have approval for the prevention of vesicoureteral reflux, a major cause of patient discomfort. RELIEF's unique ...

The Ureteral Stent Market is expected to grow at a 4.4% CAGR from 2022 to 2032, reaching US$ 385.9 million in 2022 and US$ 616.8 million by 2032. The ability of ureteral stents to restore urine flow ...

From 2022 to 2032, the Ureteral Stent Market is expected to grow at a 4.4% CAGR, reaching US$ 385.9 million in 2022 and US$ 616.8 million by 2032. Ureteral stents are in high demand due to their ...

...one must weigh the risk of resultant sequelae without a stent against [their related] morbidity Ureteral stents are routinely placed following ureteral stone lithotripsy to relieve acute ureteral ...